This was achieved by adopting the optimal experimental condition ascertained in this study, which is specified
JNK-IN-8 as 7 mJ laser energy, 1.3 kPa helium pressure, and 50 mu s measurement window, and which was found to result in consistent D emission enhancement. Employing these operational parameters, a linear calibration line exhibiting a zero intercept was obtained from zircaloy-4 samples doped with various concentrations of D impurity, regarded as surrogates for H impurity. An additional measurement also yielded a detection limit of about 10 mu g/g for D impurity, well below the acceptable threshold of damaging H concentration in zircaloy. Each of these measurements was found to produce a crater size of only 25 mu m in diameter, promising its application for performing less-destructive measurements. The result of this study has thus paved the way for conducting a further experiment with hydrogen-doped zircaloy samples and the further technical development of a selleck chemicals three-dimensional quantitative micro-analysis of detrimental hydrogen impurity in zircaloy vessels used in nuclear power plants. (C) 2011 American Institute of Physics. [doi:10.1063/1.3631776]“
“Background: Diverse growth factors secreted from human adipocyte-derived stem cells (hASCs) that support or manage adjacent
cells have been studied for therapeutic potentials to Staurosporine clinical trial a variety of pathological models. However, senescent growth arrest in hASCs during in vitro culture and subsequent defective differentiation potential, have been technical barriers to further genetic modification of hASCs for functional improvement.
Objective: We investigated the feasibility of long-term hASC culture to enhance their therapeutic use.
Methods: We used a MYC variant to generate hASCs expressing v-myc and determined their growth potential and growth factor secretion profile. We further introduced an AICT
variant to generate constitutively active (CA)-Akt/v-myc hASCs. Finally, we tested the ability of promoting wound healing of medium conditioned with CA-Akt/v-myc hASCs.
Results: The v-myc hASCs actively proliferated longer than control hASCs. Increased secretion of vascular endothelial growth factor (VEGF) by v-myc hASCs promoted the migration potential of hASCs and vasculogenesis in co-cultured endothelial cells. Additional genetic modification of v-myc hASCs using CA-Akt further increased VEGF secretion. In addition, injection of CA-Akt/v-myc hASCs-CM into wound-mice model promoted wound healing compared to normal hASCs-CM.
Conclusion: Genetic modification of hASCs to stimulate secretion of growth factors is a novel strategy to maximize their paracrine effect and improve their therapeutic potential. (C) 2012 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.